Peart TM - Search Results

1

Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.

McGee J, Peart TM, Foley N, Bertrand M, Prefontaine M, Sugimoto A, Ettler H, Welch S, Panabaker K. McGee J, et al. Among authors: peart tm. J Oncol. 2019 Apr 2;2019:6029097. doi: 10.1155/2019/6029097. eCollection 2019. J Oncol. 2019. PMID: 31061661 Free PMC article.

2

Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.

Peart T, Ramos Valdes Y, Correa RJ, Fazio E, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG. Peart T, et al. Oncotarget. 2015 Sep 8;6(26):22424-38. doi: 10.18632/oncotarget.4211. Oncotarget. 2015. PMID: 26068970 Free PMC article.

3

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.

Correa RJ, Valdes YR, Peart TM, Fazio EN, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG. Correa RJ, et al. Among authors: peart tm. Carcinogenesis. 2014 Sep;35(9):1951-61. doi: 10.1093/carcin/bgu049. Epub 2014 Feb 22. Carcinogenesis. 2014. PMID: 24562574 Free PMC article.

4

Hysterectomy in Ontario: A Population-Based Study of Outcomes and Complications in Minimally Invasive Compared with Abdominal Approaches.

Kelly EC, Winick-Ng J, McClure JA, Peart T, Chou Q, MacMillan B, Leong Y, Vilos A, Vilos G, Welk B, McGee J. Kelly EC, et al. J Obstet Gynaecol Can. 2019 Aug;41(8):1168-1176. doi: 10.1016/j.jogc.2018.10.026. Epub 2019 Jan 25. J Obstet Gynaecol Can. 2019. PMID: 30686606

5

BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.

Peart TM, Correa RJ, Valdes YR, Dimattia GE, Shepherd TG. Peart TM, et al. Clin Exp Metastasis. 2012 Apr;29(4):293-313. doi: 10.1007/s10585-011-9451-3. Epub 2012 Jan 17. Clin Exp Metastasis. 2012. PMID: 22249415

6

Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.

Correa RJ, Peart T, Valdes YR, DiMattia GE, Shepherd TG. Correa RJ, et al. Carcinogenesis. 2012 Jan;33(1):49-58. doi: 10.1093/carcin/bgr241. Epub 2011 Oct 31. Carcinogenesis. 2012. PMID: 22045027

7

A truncated RHAMM protein for discovering novel therapeutic peptides.

Hauser-Kawaguchi A, Tolg C, Peart T, Milne M, Turley EA, Luyt LG. Hauser-Kawaguchi A, et al. Bioorg Med Chem. 2018 Oct 1;26(18):5194-5203. doi: 10.1016/j.bmc.2018.09.018. Epub 2018 Sep 18. Bioorg Med Chem. 2018. PMID: 30249497

8

Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.

Bahrami SB, Tolg C, Peart T, Symonette C, Veiseh M, Umoh JU, Holdsworth DW, McCarthy JB, Luyt LG, Bissell MJ, Yazdani A, Turley EA. Bahrami SB, et al. Integr Biol (Camb). 2017 Mar 1;9(3):223-237. doi: 10.1039/c7ib00002b. Epub 2017 Feb 20. Integr Biol (Camb). 2017. PMID: 28217782 Free PMC article.

9

Corrigendum to "A truncated RHAMM protein for discovering novel therapeutic peptides" [Bioorg. Med. Chem. 26 (2018) 5194-5203].

Hauser-Kawaguchi A, Tolg C, Peart T, Milne M, Turley EA, Luyt LG. Hauser-Kawaguchi A, et al. Bioorg Med Chem. 2020 Jul 1;28(13):115543. doi: 10.1016/j.bmc.2020.115543. Epub 2020 May 16. Bioorg Med Chem. 2020. PMID: 32423782 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters